RefBan

Referral Banners

Monday, December 9, 2013

ScienceDaily: Top Health News

ScienceDaily: Top Health News


Concussion secrets unveiled in mice and people

Posted: 08 Dec 2013 10:36 AM PST

There is more than meets the eye following even a mild traumatic brain injury. While the brain may appear to be intact, new findings suggest that the brain's protective coverings may feel the brunt of the impact.

Flipping a gene switch reactivates fetal hemoglobin, may reverse sickle cell disease

Posted: 08 Dec 2013 10:36 AM PST

Hematology researchers have manipulated key biological events in adult blood cells to produce a form of hemoglobin normally absent after the newborn period. Because fetal hemoglobin is unaffected by the genetic defect in sickle cell disease, these cell culture findings may open the door to a new therapy for the debilitating blood disorder.

Gene promotes one in a hundred of tumors: Gene discovered to play a part in one per cent of all cancers

Posted: 08 Dec 2013 10:35 AM PST

Researchers have identified a gene that drives the development of tumors in over one per cent of all cancer patients. This is the first time that the gene CUX1 has been broadly linked to cancer development.

Gene expression changes with meditation

Posted: 08 Dec 2013 06:03 AM PST

With evidence growing that meditation can have beneficial health effects, scientists have sought to understand how these practices physically affect the body. A new study reports the first evidence of specific molecular changes in the body following a period of mindfulness meditation.

International gene therapy trial for 'bubble boy' disease shows promising early results

Posted: 08 Dec 2013 06:03 AM PST

Researchers reported promising outcomes data for the first group of boys with X-linked severe combined immunodeficiency syndrome, a fatal genetic immunodeficiency also known as "bubble boy" disease, who were treated as part of an international clinical study of a new form of gene therapy. Its delivery mechanism was designed to prevent the leukemia that arose a decade ago in a similar trial in Europe.

No comments: